InnovAge Holding Corp. (NASDAQ:INNV - Free Report) - Analysts at William Blair issued their Q4 2025 earnings estimates for shares of InnovAge in a report released on Tuesday, May 6th. William Blair analyst J. Haase forecasts that the company will post earnings per share of ($0.01) for the quarter. The consensus estimate for InnovAge's current full-year earnings is ($0.12) per share.
InnovAge (NASDAQ:INNV - Get Free Report) last issued its earnings results on Tuesday, May 6th. The company reported ($0.08) EPS for the quarter, missing analysts' consensus estimates of ($0.02) by ($0.06). InnovAge had a negative net margin of 3.19% and a negative return on equity of 9.45%. The business had revenue of $218.14 million during the quarter, compared to analysts' expectations of $214.09 million.
InnovAge Trading Down 0.3%
Shares of INNV stock traded down $0.01 during mid-day trading on Thursday, reaching $3.79. The company's stock had a trading volume of 15,432 shares, compared to its average volume of 52,805. The company's 50 day simple moving average is $3.06 and its 200-day simple moving average is $3.83. InnovAge has a 12-month low of $2.60 and a 12-month high of $6.69. The company has a quick ratio of 1.16, a current ratio of 1.16 and a debt-to-equity ratio of 0.27. The firm has a market capitalization of $512.57 million, a PE ratio of -19.95 and a beta of 0.40.
Institutional Trading of InnovAge
Several large investors have recently bought and sold shares of the company. Barclays PLC lifted its holdings in InnovAge by 289.0% in the 3rd quarter. Barclays PLC now owns 25,614 shares of the company's stock worth $154,000 after buying an additional 19,029 shares in the last quarter. JPMorgan Chase & Co. lifted its holdings in InnovAge by 191.5% in the 3rd quarter. JPMorgan Chase & Co. now owns 24,687 shares of the company's stock worth $148,000 after buying an additional 16,217 shares in the last quarter. SG Americas Securities LLC acquired a new position in InnovAge in the 4th quarter worth $43,000. Renaissance Technologies LLC lifted its holdings in InnovAge by 14.5% in the 4th quarter. Renaissance Technologies LLC now owns 162,000 shares of the company's stock worth $637,000 after buying an additional 20,500 shares in the last quarter. Finally, T. Rowe Price Investment Management Inc. lifted its holdings in InnovAge by 5.9% in the 4th quarter. T. Rowe Price Investment Management Inc. now owns 5,037,688 shares of the company's stock worth $19,799,000 after buying an additional 281,551 shares in the last quarter. Institutional investors and hedge funds own 12.26% of the company's stock.
About InnovAge
(
Get Free Report)
InnovAge Holding Corp. manages and provides a range of medical and ancillary services for seniors in need of care and support to live independently in its homes and communities. The company manages its business through Program of All-Inclusive Care for the Elderly (PACE) approach. It also offers in-home care services consisting of skilled, unskilled, and personal care; in-center services, such as primary care, physical therapy, occupational therapy, speech therapy, dental services, mental health and psychiatric services, meals, and activities; transportation to the PACE center and third-party medical appointments; and care management.
Featured Articles
Before you consider InnovAge, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and InnovAge wasn't on the list.
While InnovAge currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
